Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?

被引:9
作者
Connolly, D. [1 ,2 ]
Black, A. [2 ]
Murray, L. J. [2 ]
Nambirajan, T. [1 ]
Keane, P. F. [1 ]
Gavin, A. [3 ]
机构
[1] Belfast City Hosp, Dept Urol, Belfast BT9 7AB, Antrim, North Ireland
[2] Queens Univ Belfast, Canc Epidemiol & Prevent Res Grp, Belfast, Antrim, North Ireland
[3] Queens Univ Belfast, No Ireland Canc Registry, Belfast, Antrim, North Ireland
关键词
decrease; pattern; PSA; variability; BIOLOGICAL VARIATION; CANCER DETECTION; MEN; VOLUNTEERS;
D O I
10.1038/pcan.2008.37
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To examine the practice of repeating an abnormal prostate-specific antigen (PSA) level before proceeding to prostate biopsy, we assessed the pattern of PSA change following an initially raised (>= 4.0 ng ml(-1)) PSA, and the relationship of this to prostate cancer diagnosis. In 7052 men, 71.2% with initially raised PSA had a reduction in PSA, with values <4.0 ng ml(-1) in 37.8%. A total of 43.0% of men with prostate cancer showed a PSA decrease below their baseline level. Short-term decreases in PSA may occur in men with prostate cancer, including high-grade cancer, and so should not influence the decision to proceed to prostate biopsy.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 15 条
[1]   An elevated PSA, which normalizes, does not exclude the presence of prostate cancer [J].
Boddy, JL ;
Pike, DJ ;
Al-Hayek, S ;
Shaida, N ;
Malone, PR .
PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (04) :349-352
[2]   PROSTATE-SPECIFIC ANTIGEN VARIABILITY IN MEN WITHOUT PROSTATE-CANCER - EFFECT OF SAMPLING INTERVAL ON PROSTATE-SPECIFIC ANTIGEN VELOCITY [J].
CARTER, HB ;
PEARSON, JD ;
WACLAWIW, Z ;
METTER, EJ ;
CHAN, DW ;
GUESS, HA ;
WALSH, PC .
UROLOGY, 1995, 45 (04) :591-596
[3]   LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].
CARTER, HB ;
PEARSON, JD ;
METTER, J ;
BRANT, LJ ;
CHAN, DW ;
ANDRES, R ;
FOZARD, JL ;
WALSH, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2215-2220
[4]   Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: Diagnosis is dependent on the intensity of investigation [J].
Connolly, David ;
Black, Amanda ;
Gavin, Anna ;
Keane, Patrick F. ;
Murray, Liam J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) :271-278
[5]   Variation of serum prostate-specific antigen levels - An evaluation of year-to-year fluctuations [J].
Eastham, JA ;
Riedel, E ;
Scardino, PT ;
Shike, M ;
Fleisher, M ;
Schatzkin, A ;
Lanza, E ;
Latkany, L ;
Begg, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (20) :2695-2700
[6]   Evidence of prostate cancer screening in a UK region [J].
Kirby, R .
BJU INTERNATIONAL, 2004, 93 (06) :734-734
[7]   The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study [J].
Hamdy, FC ;
Dedman, D ;
Lane, A ;
Oliver, S ;
Powell, P ;
Leung, H ;
Gillatt, D ;
Neal, DE ;
Donovan, JL .
JOURNAL OF UROLOGY, 2006, 175 (04) :153-153
[8]   Natural history of PSA increase with and without prostate cancer [J].
Ito, K ;
Yamamato, T ;
Ohi, M ;
Takeuchi, H ;
Kurokawa, K ;
Suzuki, K ;
Yamanaka, H .
UROLOGY, 2003, 62 (01) :64-69
[9]   CHARACTERISTICS OF PROSTATE-CANCER DETECTED IN THE AMERICAN-CANCER-SOCIETY NATIONAL PROSTATE-CANCER DETECTION PROJECT [J].
METTLIN, C ;
MURPHY, GP ;
LEE, F ;
LITTRUP, PJ ;
CHESLEY, A ;
BABAIAN, R ;
BADALAMENT, R ;
KANE, RA ;
MOSTOFI, FK ;
MCAULEY, C ;
CHURCH, P ;
BURGERS, J ;
TOI, A ;
GILBAUGH, JH .
JOURNAL OF UROLOGY, 1994, 152 (05) :1737-1740
[10]   Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers [J].
Ornstein, DK ;
Smith, DS ;
Rao, GS ;
Basler, JW ;
Ratliff, TL ;
Catalona, WJ .
JOURNAL OF UROLOGY, 1997, 157 (06) :2179-2182